+90 216 544 0 544
growthmarkets@curiumpharma.com.tr
Order Form
About Us
Facilities
Affiliates
About Us
Products
Contributions to SDGS
Projects
Policies
Sustainability
Innovation
CDMO
News
Contact
About Us
Facilities
Affiliates
About Us
Products
Contributions to SDGS
Projects
Policies
Sustainability
Innovation
CDMO
News
Contact
+90 216 544 0 544
Press-center
28
March
2025
January 20th, 2026
Curium Completes The Acquisition Of Monrol As Part Of Its Plan To Significantly Expand Lutetium-177 Capacity And Pet Footprint